Sahajanand Medical Technologies Pvt. Ltd.(SMT), India’s largest manufacturer of cardiovascular medical stents, recently announces the cardiac stents and catheters tender win in Romania at the “Institute de Boli Cardivasculare Prof. Dr. G. I. M. Georgescu” Hospital.

The hospital is best known for interventional cardiology with around 800 primary PCIs and about 1200 elective PCIs conducted regularly. The hospital also performs all major and advanced procedures like complex coronary angioplasties, bifurcations, Valvoplasties and TAVI.

The hospital is a tertiary care center in “Iasi” town of Moldavia region in North-East Romania which caters to around 4 million people. SMT started the operations in Romania towards the end of 2015, and worked with clinicians for PTCA balloon and drug eluting stents evaluations.

Commenting on the successful achievement Cheran Uthirapathi, VP, international marketing and sales, SMT said, “The doctors of ‘Institute de Boli Cardivasculare Prof. Dr. G. I. M. Georgescu Hospital’ are pleased with the successful outcomes of Supraflex (DES). The easy use of Supraflex makes it a preferred choice among doctors for their patients. We understand the responsibility of building a strong trust with  clinicians and we are happy to undertake the duty of keeping more than 1,000 Romanian hearts safely beating with our stents and balloons.”

Ganesh Sabat, CEO, SMT said; “We are delighted to win the order of supplying Supralfex stents in Romina Lasi Hospital. This win reflects the hard work of the SMT Team and their pledge to save millions. We have always worked towards maintaining the safety and efficacy of our stents. Supraflex has shown excellent deliverability and safety which is essential for PCI procedures, thereby becoming a good choice for physicians. We will continue to work towards serving this institution with pride and passion.”

SMT is a leading medical devices company specializing in the provision of life-changing vascular solutions. SMT offers an extensive portfolio of products that set industry benchmarks in vascular intervention by being the 1st company in the world to receive CE approval for DES with biodegradable polymer. Other distinguished ‘benefactio’ include ultrathin (60µm) lowest strut thickness for all the DES options offered by the company. Company has global presence with its footprints in more than 60 countries.